US Stock MarketDetailed Quotes

PMCB PharmaCyte Biotech

Watchlist
  • 1.640
  • 0.0000.00%
Close Dec 20 16:00 ET
11.43MMarket Cap1.86P/E (TTM)

PharmaCyte Biotech Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
(Q2)Oct 31, 2023
(Q1)Jul 31, 2023
(FY)Apr 30, 2023
(Q4)Apr 30, 2023
(Q3)Jan 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-71.62%20.84M
-56.29%32.64M
-26.25%50.18M
-26.25%50.18M
-15.73%61.21M
-4.60%73.43M
-9.20%74.66M
-20.33%68.04M
-20.33%68.04M
-16.16%72.64M
-Cash and cash equivalents
-71.62%20.84M
-56.29%32.64M
-26.25%50.18M
-26.25%50.18M
-15.73%61.21M
-4.60%73.43M
-9.20%74.66M
-20.33%68.04M
-20.33%68.04M
-16.16%72.64M
Other current assets
52.61%493.21K
170.98%240.23K
141.27%259.8K
141.27%259.8K
64.50%297.76K
--323.19K
--88.65K
--107.68K
--107.68K
--181.01K
Total current assets
-71.07%21.33M
-56.02%32.88M
-25.98%50.44M
-25.98%50.44M
-15.54%61.51M
-4.49%73.75M
-9.12%74.75M
-20.29%68.15M
-20.29%68.15M
-16.12%72.82M
Non current assets
Goodwill and other intangible assets
-56.35%1.55M
-56.35%1.55M
-56.35%1.55M
-56.35%1.55M
0.00%3.55M
0.00%3.55M
0.00%3.55M
0.00%3.55M
0.00%3.55M
0.00%3.55M
-Other intangible assets
----
----
--1.55M
--1.55M
0.00%3.55M
0.00%3.55M
0.00%3.55M
----
----
0.00%3.55M
Investments and advances
1,480.91%24.86M
1,752.19%29.12M
--0
--0
0.00%1.57M
0.00%1.57M
0.00%1.57M
0.00%1.57M
0.00%1.57M
0.00%1.57M
Long-term notes receivables
--3.44M
--3M
--2.76M
--2.76M
--2.01M
----
----
--0
--0
----
Financial assets
--3.92M
--3.64M
--5.15M
--5.15M
--2.71M
----
----
--0
--0
----
Other non current assets
0.00%7.69K
0.00%7.69K
0.00%7.69K
0.00%7.69K
0.00%7.69K
0.00%7.69K
0.00%7.69K
0.00%7.69K
0.00%7.69K
0.00%7.69K
Total non current assets
558.28%33.77M
627.57%37.32M
84.51%9.46M
84.51%9.46M
92.06%9.85M
0.00%5.13M
0.00%5.13M
0.00%5.13M
0.00%5.13M
0.00%5.13M
Total assets
-30.15%55.1M
-12.13%70.19M
-18.25%59.9M
-18.25%59.9M
-8.46%71.36M
-4.21%78.88M
-8.59%79.88M
-19.14%73.28M
-19.14%73.28M
-15.22%77.95M
Liabilities
Current liabilities
Payables
3,411.79%4.43M
-13.15%901.45K
291.38%729.44K
291.38%729.44K
8.58%484.2K
-85.35%126.16K
85.68%1.04M
-9.24%186.38K
-9.24%186.38K
380.22%445.94K
-accounts payable
176.31%348.6K
-22.86%553.95K
203.53%389.37K
203.53%389.37K
8.58%484.2K
-85.35%126.16K
28.46%718.13K
-37.53%128.28K
-37.53%128.28K
380.22%445.94K
-Total tax payable
--361.53K
--347.49K
485.36%340.07K
485.36%340.07K
----
----
----
--58.1K
--58.1K
----
-Dividends payable
--3.72M
----
----
----
----
----
--319.85K
----
----
----
Current accrued expenses
-66.05%345.66K
-29.87%336.64K
-1.27%395.13K
-1.27%395.13K
102.79%774.44K
126.33%1.02M
-9.48%480.04K
-19.80%400.2K
-19.80%400.2K
-26.57%381.9K
Other current liabilities
----
--6.23M
--6.3M
--6.3M
--6.28M
--4.1M
----
----
----
----
Current liabilities
-8.84%4.78M
392.28%7.47M
1,165.17%7.42M
1,165.17%7.42M
810.66%7.54M
299.62%5.24M
39.35%1.52M
-16.72%586.58K
-16.72%586.58K
35.05%827.83K
Non current liabilities
Derivative product liabilities
-55.88%6.87M
-48.73%9.68M
--12.97M
--12.97M
--14.93M
--15.57M
--18.88M
--0
--0
----
Total non current liabilities
-55.88%6.87M
-48.73%9.68M
--12.97M
--12.97M
--14.93M
--15.57M
--18.88M
--0
--0
--0
Total liabilities
-44.04%11.65M
-15.90%17.15M
3,375.95%20.39M
3,375.95%20.39M
2,613.80%22.47M
1,487.38%20.81M
1,772.39%20.4M
-16.72%586.58K
-16.72%586.58K
35.05%827.83K
Shareholders'equity
Share capital
-99.99%2.17K
-68.16%5.34M
549,399.21%11.87M
549,399.21%11.87M
811,051.25%17.52M
986,003.52%21.3M
775,605.65%16.76M
4.25%2.16K
4.25%2.16K
4.25%2.16K
-common stock
0.00%2.17K
0.00%2.17K
0.32%2.17K
0.32%2.17K
0.32%2.17K
0.32%2.17K
0.32%2.17K
4.25%2.16K
4.25%2.16K
4.25%2.16K
-Preferred stock
--0
-68.17%5.33M
--11.87M
--11.87M
--17.52M
--21.3M
--16.75M
--0
--0
----
Retained earnings
19.49%-93.67M
22.82%-92.2M
0.29%-115.63M
0.29%-115.63M
-0.98%-116.97M
-1.11%-116.35M
-5.54%-119.46M
-3.86%-115.96M
-3.86%-115.96M
-5.09%-115.84M
Paid-in capital
-6.32%181.35M
-9.65%182.72M
-8.36%185.33M
-8.36%185.33M
-6.43%189.22M
-3.97%193.59M
0.32%202.23M
0.32%202.23M
0.32%202.23M
0.33%202.23M
Less: Treasury stock
9.29%44.21M
6.93%42.79M
210.02%42.04M
210.02%42.04M
341.47%40.85M
638.68%40.45M
1,813.96%40.02M
--13.56M
--13.56M
--9.25M
Gains losses not affecting retained earnings
3.63%-23.27K
-3.44%-23.33K
-2.21%-23.51K
-2.21%-23.51K
-30.16%-23.07K
-59.12%-24.14K
-56.04%-22.55K
-45.99%-23K
-45.99%-23K
8.16%-17.73K
Total stockholders'equity
-25.17%43.45M
-10.83%53.04M
-45.64%39.51M
-45.64%39.51M
-36.60%48.89M
-28.35%58.07M
-31.07%59.48M
-19.16%72.69M
-19.16%72.69M
-15.56%77.12M
Total equity
-25.17%43.45M
-10.83%53.04M
-45.64%39.51M
-45.64%39.51M
-36.60%48.89M
-28.35%58.07M
-31.07%59.48M
-19.16%72.69M
-19.16%72.69M
-15.56%77.12M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024(Q2)Oct 31, 2023(Q1)Jul 31, 2023(FY)Apr 30, 2023(Q4)Apr 30, 2023(Q3)Jan 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -71.62%20.84M-56.29%32.64M-26.25%50.18M-26.25%50.18M-15.73%61.21M-4.60%73.43M-9.20%74.66M-20.33%68.04M-20.33%68.04M-16.16%72.64M
-Cash and cash equivalents -71.62%20.84M-56.29%32.64M-26.25%50.18M-26.25%50.18M-15.73%61.21M-4.60%73.43M-9.20%74.66M-20.33%68.04M-20.33%68.04M-16.16%72.64M
Other current assets 52.61%493.21K170.98%240.23K141.27%259.8K141.27%259.8K64.50%297.76K--323.19K--88.65K--107.68K--107.68K--181.01K
Total current assets -71.07%21.33M-56.02%32.88M-25.98%50.44M-25.98%50.44M-15.54%61.51M-4.49%73.75M-9.12%74.75M-20.29%68.15M-20.29%68.15M-16.12%72.82M
Non current assets
Goodwill and other intangible assets -56.35%1.55M-56.35%1.55M-56.35%1.55M-56.35%1.55M0.00%3.55M0.00%3.55M0.00%3.55M0.00%3.55M0.00%3.55M0.00%3.55M
-Other intangible assets ----------1.55M--1.55M0.00%3.55M0.00%3.55M0.00%3.55M--------0.00%3.55M
Investments and advances 1,480.91%24.86M1,752.19%29.12M--0--00.00%1.57M0.00%1.57M0.00%1.57M0.00%1.57M0.00%1.57M0.00%1.57M
Long-term notes receivables --3.44M--3M--2.76M--2.76M--2.01M----------0--0----
Financial assets --3.92M--3.64M--5.15M--5.15M--2.71M----------0--0----
Other non current assets 0.00%7.69K0.00%7.69K0.00%7.69K0.00%7.69K0.00%7.69K0.00%7.69K0.00%7.69K0.00%7.69K0.00%7.69K0.00%7.69K
Total non current assets 558.28%33.77M627.57%37.32M84.51%9.46M84.51%9.46M92.06%9.85M0.00%5.13M0.00%5.13M0.00%5.13M0.00%5.13M0.00%5.13M
Total assets -30.15%55.1M-12.13%70.19M-18.25%59.9M-18.25%59.9M-8.46%71.36M-4.21%78.88M-8.59%79.88M-19.14%73.28M-19.14%73.28M-15.22%77.95M
Liabilities
Current liabilities
Payables 3,411.79%4.43M-13.15%901.45K291.38%729.44K291.38%729.44K8.58%484.2K-85.35%126.16K85.68%1.04M-9.24%186.38K-9.24%186.38K380.22%445.94K
-accounts payable 176.31%348.6K-22.86%553.95K203.53%389.37K203.53%389.37K8.58%484.2K-85.35%126.16K28.46%718.13K-37.53%128.28K-37.53%128.28K380.22%445.94K
-Total tax payable --361.53K--347.49K485.36%340.07K485.36%340.07K--------------58.1K--58.1K----
-Dividends payable --3.72M----------------------319.85K------------
Current accrued expenses -66.05%345.66K-29.87%336.64K-1.27%395.13K-1.27%395.13K102.79%774.44K126.33%1.02M-9.48%480.04K-19.80%400.2K-19.80%400.2K-26.57%381.9K
Other current liabilities ------6.23M--6.3M--6.3M--6.28M--4.1M----------------
Current liabilities -8.84%4.78M392.28%7.47M1,165.17%7.42M1,165.17%7.42M810.66%7.54M299.62%5.24M39.35%1.52M-16.72%586.58K-16.72%586.58K35.05%827.83K
Non current liabilities
Derivative product liabilities -55.88%6.87M-48.73%9.68M--12.97M--12.97M--14.93M--15.57M--18.88M--0--0----
Total non current liabilities -55.88%6.87M-48.73%9.68M--12.97M--12.97M--14.93M--15.57M--18.88M--0--0--0
Total liabilities -44.04%11.65M-15.90%17.15M3,375.95%20.39M3,375.95%20.39M2,613.80%22.47M1,487.38%20.81M1,772.39%20.4M-16.72%586.58K-16.72%586.58K35.05%827.83K
Shareholders'equity
Share capital -99.99%2.17K-68.16%5.34M549,399.21%11.87M549,399.21%11.87M811,051.25%17.52M986,003.52%21.3M775,605.65%16.76M4.25%2.16K4.25%2.16K4.25%2.16K
-common stock 0.00%2.17K0.00%2.17K0.32%2.17K0.32%2.17K0.32%2.17K0.32%2.17K0.32%2.17K4.25%2.16K4.25%2.16K4.25%2.16K
-Preferred stock --0-68.17%5.33M--11.87M--11.87M--17.52M--21.3M--16.75M--0--0----
Retained earnings 19.49%-93.67M22.82%-92.2M0.29%-115.63M0.29%-115.63M-0.98%-116.97M-1.11%-116.35M-5.54%-119.46M-3.86%-115.96M-3.86%-115.96M-5.09%-115.84M
Paid-in capital -6.32%181.35M-9.65%182.72M-8.36%185.33M-8.36%185.33M-6.43%189.22M-3.97%193.59M0.32%202.23M0.32%202.23M0.32%202.23M0.33%202.23M
Less: Treasury stock 9.29%44.21M6.93%42.79M210.02%42.04M210.02%42.04M341.47%40.85M638.68%40.45M1,813.96%40.02M--13.56M--13.56M--9.25M
Gains losses not affecting retained earnings 3.63%-23.27K-3.44%-23.33K-2.21%-23.51K-2.21%-23.51K-30.16%-23.07K-59.12%-24.14K-56.04%-22.55K-45.99%-23K-45.99%-23K8.16%-17.73K
Total stockholders'equity -25.17%43.45M-10.83%53.04M-45.64%39.51M-45.64%39.51M-36.60%48.89M-28.35%58.07M-31.07%59.48M-19.16%72.69M-19.16%72.69M-15.56%77.12M
Total equity -25.17%43.45M-10.83%53.04M-45.64%39.51M-45.64%39.51M-36.60%48.89M-28.35%58.07M-31.07%59.48M-19.16%72.69M-19.16%72.69M-15.56%77.12M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.